PGLYRP1 and cardiovascular disorder: Extending this point, there are reported associations between increased serum PGLYRP-1 and systemic inflammatory conditions in adulthood (e.g. rheumatoid arthritis, cardiovascular disease) (Luo et al., 2019; Rohatgi et al., 2009).